BEZOS BACKS $500M BET ON REVERSE-ENGINEERING THE BRAIN

Flourish is pursuing an ambitious goal: discovering the core computational rules governing how neurons process information. Rather than building AI from scratch, the startup plans to study biological brains directly—using advanced microscopy and analysis to extract their underlying logic. The approach represents a departure from conventional AI development. Instead of iterating on existing deep learning models, Flourish wants to decode what the brain actually does at a fundamental level, then potentially apply those principles to artificial systems. With Bezos backing and significant capital, Flourish joins a growing number of ventures exploring neuroscience-inspired AI. The company's valuation reflects investor confidence in the premise that understanding biological intelligence could unlock more efficient artificial intelligence. The startup faces substantial technical hurdles. Mapping neural circuits and translating biological processes into computational algorithms remains largely unsolved—a challenge that no amount of funding has yet cracked.